FDA Oncology Announcements

HDAC inhibitor × Clear all

4 Announcements

Panobinostat

Drugs: FARYDAK capsules (panobinostat) · HDAC inhibitor, bortezomib · Proteasome inhibitor
Condition: Plasma cell

Belinostat

Drug: BELEODAQ (belinostat) · HDAC inhibitor
Condition: Lymphoid

Romidepsin

Drugs: ISTODAX (romidepsin) · HDAC inhibitor, ISTODAX (injection)
Condition: Lymphoid

FDA approves vorinostat (Zolinza) for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma (CTCL)

Drug: Zolinza (vorinostat) · HDAC inhibitor
Condition: Lymphoid